Related Experiment Video
Updated: Apr 21, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
The Function of PPARα in Cancer Drug Development: A Promising Target for Cancer Treatment.
Rasiravathanahalli Kaveriyappan Govindarajan1,2, Ragothaman Prathiviraj3, Mohammed Qasim Waheeb4
1Department of Biotechnology, Karpagam Academy of Higher Education, Coimbatore, Tamil Nadu, 641021, India.
Peroxisome proliferator-activated receptor alpha (PPARα) modulators show promise in cancer treatment. This review explores PPARα
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cancer remains a leading global cause of mortality.
- Peroxisome proliferator-activated receptors (PPARs) and their modulators are implicated in cancer progression.
- PPARα, a nuclear hormone receptor, influences carcinogenesis through various pathological cancer behaviors.
Purpose of the Study:
- To review the current understanding of PPARα's role in different facets of cancer development.
- To summarize known modulators that regulate PPARα activity.
- To discuss the potential for developing PPARα-targeting modulators for cancer therapy.
Main Methods:
- Literature review of existing research on PPARα in cancer.
- Analysis of studies detailing PPARα's mechanisms in carcinogenesis.
- Synthesis of information on PPARα modulators and their therapeutic potential.
Main Results:
- PPARα activation influences key cancer cell behaviors, including proliferation and inflammation.
- Specific transcriptional pathways and immune responses are modulated by PPARα.
- Evidence highlights PPARα's complex role in various cancer types.
Conclusions:
- PPARα is a significant factor in cancer development and progression.
- Targeting PPARα with specific modulators presents a potential therapeutic strategy for cancer.
- Further research into PPARα modulators could lead to novel cancer treatments.
More Related Videos
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression